SCHEMBL30666275

SCHEMBL30666275

CC(C)(C)OC(=O)N1CC2(C1)CN(c1sc3nnc(Cl)cc3c1C1CC1)C2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OXTR P30559 1/20 0.39
▸ AVPR1A P37288 1/20 0.39
▸ EGLN2 Q96KS0 1/20 0.36
▸ PARP1 P09874 1/20 0.34
▸ CNR1 P21554 2/20 0.34
▸ EHMT2 Q96KQ7 1/20 0.34
▸ MAPT P10636 3/20 0.33
▸ STS P08842 1/20 0.33
▸ CYP11B2 P19099 1/20 0.33
▸ GPR119 Q8TDV5 3/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ RORC P51449 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ USP30 Q70CQ3 1/20 0.33
▸ SCD5 Q86SK9 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26683384 1.00 OXTR (0.39) OXTRAVPR1AEGLN2PARP1CNR1
SCHEMBL26683497 0.86 OXTR (0.37) OXTRAVPR1AEGLN2PARP1EHMT2
SCHEMBL30666279 0.86 OXTR (0.37) OXTRAVPR1AEGLN2PARP1EHMT2
SCHEMBL26683430 0.85 OXTR (0.42) OXTRAVPR1APARP1CNR1EHMT2
SCHEMBL30666269 0.85 OXTR (0.42) OXTRAVPR1APARP1CNR1EHMT2
SCHEMBL26683323 0.83 SMARCA2 (0.47) OXTRAVPR1AEGLN2PARP1CYP11B2
SCHEMBL26683610 0.76 OXTR (0.43) OXTRAVPR1AEGLN2CNR1EHMT2
SCHEMBL30666241 0.73 OXTR (0.39) OXTRAVPR1AEGLN2PARP1EHMT2
SCHEMBL26683395 0.73 OXTR (0.39) OXTRAVPR1AEGLN2PARP1EHMT2
SCHEMBL30666273 0.73 OXTR (0.45) OXTRAVPR1AEGLN2EHMT2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4522277-A1 PYRAZINE DERIVATIVES AND USES THEREOF Foghorn Therapeutics Inc. (US) 2025-03-19 — — EP disclosed
WO-2023220137-A1 PYRAZINE DERIVATIVES AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2023-11-16 — — WO disclosed
Send feedback